Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67749-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- CD70 antibody
- Antibody type
- Monoclonal
- Description
- CD70 antibody (Cat. #67749-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1A11A10
- Vial size
- 20ul, 150ul
Submitted references Single-cell and bulk transcriptomics reveal a CD8(+) T-cell gene signature predicting prognosis in diffuse large B-cell lymphoma.
CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GVHD.
Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
Comprehensive molecular characterization of long-term glioblastoma survivors.
Special issue "The advance of solid tumor research in China": Multi-omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response.
Liu H, Feng Y, Qian Z, Song Z, Zhang N, Yu J, Liu X, Qiu L, Zhou S, Gong W, Meng B, Abolhassani H, Asghar M, Li L, He J, Zhang H, Wang X
Frontiers in immunology 2025;16:1685541
Frontiers in immunology 2025;16:1685541
CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GVHD.
Verma K, Croft W, Margielewska-Davies S, Pearce H, Stephens C, Diaconescu D, Bevington S, Craddock C, Amel-Kashipaz R, Zuo J, Kinsella FAM, Moss P
Blood advances 2024 Sep 24;8(18):4900-4912
Blood advances 2024 Sep 24;8(18):4900-4912
Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
Cao W, Lan J, Hu C, Kong J, Xiang L, Zhang Z, Sun Y, Zeng Z, Lei S
Aging 2024 Mar 18;16(6):5618-5633
Aging 2024 Mar 18;16(6):5618-5633
Comprehensive molecular characterization of long-term glioblastoma survivors.
Xu H, Chen X, Sun Y, Hu X, Zhang X, Wang Y, Tang Q, Zhu Q, Song K, Chen H, Sheng X, Yao Y, Zhuang D, Chen L, Mao Y, Qin Z
Cancer letters 2024 Jul 1;593:216938
Cancer letters 2024 Jul 1;593:216938
Special issue "The advance of solid tumor research in China": Multi-omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response.
Tian X, Wang Y, Xu W, Tang H, Zhu S, Anwaier A, Liu W, Wang W, Zhu W, Su J, Qu Y, Zhang H, Ye D
International journal of cancer 2023 Jan 1;152(1):66-78
International journal of cancer 2023 Jan 1;152(1):66-78
No comments: Submit comment
No validations: Submit validation data